Fundraising FoxCalosyn Pharma
Shreveport, US · Founded 2007 · Delaware corporation · 1 known investors
Find your way into Calosyn Pharma
Sign up to see every warm intro you have to Calosyn Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Calosyn Pharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Developing intra-articular ion channel modulator therapeutics for osteoarthritis of the knee.
Founders & leadership
WR
William R. GrimesPresident and Chief Executive Officer
SS
Stephen SnowdyExecutive
DW
David WaddellNamed on SEC filing
RP
Ross P. BarrettSecretary
Board
JL
RB
MS
Mike ShermanBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$1.1M disclosed across 2 rounds · 2012–2022
▶$750KraisedMar 2024 · 7 investors · BiotechnologyRule 506(b)
▶$750KraisedMar 2024 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joseph LovettDirector
- Richard BabbExecutive Officer, Director
- David WaddellDirector
- Ross P. BarrettExecutive Officer, Director
- William R. GrimesExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $750K
- Proceeds to insiders
- $144K
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$309.7KraisedFeb 2012 · 3 investors · BiotechnologyRule 506(b)
▶$309.7KraisedFeb 2012 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David WaddellDirector
- Stephen SnowdyExecutive Officer, Director
- Ross BarrettDirector
- Joseph LovettDirector
- Mike ShermanDirector
- Offering amount
- $2.1M
- Amount sold
- $309.7K
- First sale
- Feb 2012
- Incorporated
- Corporation, Delaware, 2007
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Calosyn Pharma do?
- Developing intra-articular ion channel modulator therapeutics for osteoarthritis of the knee.
- Who are Calosyn Pharma's investors?
- Calosyn Pharma's investors include Louisiana Funds.
- How much funding has Calosyn Pharma raised?
- Calosyn Pharma has disclosed $1.1M raised across 2 rounds.
- Where is Calosyn Pharma headquartered?
- Calosyn Pharma is headquartered in Shreveport, US.